Second priority articles (R2, Moderate portion of articles likely to be relevant):
Sequence

Last updated: 2024 Oct 18
Total hit(s): 7433
S.No.
1
38717833
China's policies: post-COVID-19 challenges for the older population.
Glob Health Action
2024 Dec 31
1.91
1
2
39376996
Inhibition of SARS-CoV-2 growth in the lungs of mice by a peptide-conjugated morpholino oligomer targeting viral RNA.
Mol Ther Nucleic Acids
2024 Dec 10
1
3
39355526
ENaC gene variants and their involvement in Covid19 severity.
Biomed Rep
2024 Dec
1.8
1
4
38779718
SARS-CoV-2 omicron BA.2.87.1 exhibits higher susceptibility to serum neutralization than EG.5.1 and JN.1.
Emerg Microbes Infect
2024 Dec
5.84
2
5
38616729
Antigenicity assessment of SARS-CoV-2 saltation variant BA.2.87.1.
Emerg Microbes Infect
2024 Dec
5.84
2
6
39345340
Genomic analysis of the SARS-CoV-2 variants circulated in the Philippines, 2020-2024.
Dialogues Health
2024 Dec
1
7
39268173
SARS-CoV-2 infection of domestic animals and their role in evolution and emergence of variants of concern.
New Microbes New Infect
2024 Dec
1.6
1
8
39288992
Clonal landscape of autoantibody-secreting plasmablasts in COVID-19 patients.
Life Sci Alliance
2024 Dec
- n/a -
1
9
38885134
Modes of delivery and indications in women with COVID-19: a regional observational study in Japan.
J Obstet Gynaecol
2024 Dec
2.1
1
10
38828796
Prediction models for COVID-19 disease outcomes.
Emerg Microbes Infect
2024 Dec
5.84
1
11
39409149
Advancements in the Development of Anti-SARS-CoV-2 Therapeutics.
Int J Mol Sci
2024 Oct 9
4.21
1
12
39379663
A deep drug prediction framework for viral infectious diseases using an optimizer-based ensemble of convolutional neural network: COVID-19 as a case study.
Mol Divers
2024 Oct 9
3.5
1
13
39379400
Potent neutralization of SARS-CoV-2 variants by RBD nanoparticle and prefusion-stabilized spike immunogens.
NPJ Vaccines
2024 Oct 8
4.98
1
14
39378428
Shift in Demographic Involvement and Clinical Characteristics of COVID-19 From Wild-Type SARS-CoV-2 to the Delta Variant in the Indian Population: In Silico Analysis.
Interact J Med Res
2024 Oct 8
1
15
39378872
Operational Research to Support Rapid Evidence-Based Responses to Outbreaks: Learnings from COVID-19.
Am J Trop Med Hyg
2024 Oct 8
2.25
1
16
39380114
Increase in PVC-BSI during the second COVID-19 pandemic year: analysis of catheter and patient characteristics.
Antimicrob Resist Infect Control
2024 Oct 8
3.61
1
17
39384246
Development and validation of predictive models for mortality of cases with COVID-19 (Omicron BA.5.2.48 and B.7.14): a retrospective study.
BMJ Open
2024 Oct 8
2.49
1
18
39416020
Chronic infections can generate SARS-CoV-2-like bursts of viral evolution without epistasis.
bioRxiv
2024 Oct 7
- n/a -
1
19
39373506
Positive selection, genetic recombination, and intra-host evolution in novel equine coronavirus genomes and other members of the Embecovirus subgenus.
Microbiol Spectr
2024 Oct 7
4.6
1
20
39367404
Innovation bundles and platforms - a qualitative analysis of health system responses to the COVID-19 pandemic.
BMC Health Serv Res
2024 Oct 4
2.01
1
21
39361729
Omicron-specific ultra-potent SARS-CoV-2 neutralizing antibodies targeting the N1/N2 loop of Spike N-terminal domain.
Emerg Microbes Infect
2024 Oct 3
5.84
1
22
39360497
Sufrimiento psicosocial en trabajadoras migrantes latinoamericanas en tareas de cuidados en Espana y Alemania, durante la pandemia de COVID-19.
Health Educ Behav
2024 Oct 3
3.6
1
23
39412366
SARS-CoV-2 ORF 3a-mediated currents are inhibited by antiarrhythmic drugs.
Europace
2024 Oct 3
9.3
1
24
39363208
Identification and evaluation of candidate COVID-19 critical genes and medicinal drugs related to plasma cells.
BMC Infect Dis
2024 Oct 3
2.58
1
25
39368587
The SARS-CoV-2 spike protein contains a furin cleavage site located in a short loop between antiparallel beta-strands.
Int J Biol Macromol
2024 Oct 3
4.94
1